14 June 2018 EMA/418958/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: atovaquone / proguanil

Procedure no.: PSUSA/00000266/201710

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised MT

number Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid Malarone, 250 mg/100 mg õhukese polümeerikattega tabletid Malarone, filmovertrukne tabletter Malarone, filmovertrukne tabletter MALARONE 250 mg/100 mg, comprime pellicule MALARONE 62,5 mg/25 mg ENFANTS, comprimé pelliculé ATOVAQUONE/PROGUAN IL ZENTIVA 62,5 mg/25 mg ENFANTS, comprimé pelliculé ATOVAQUONE/PROGUAN ILBIOGARAN 250 mg / 100 mg, comprimé pelliculé ATOVAQUONE/PROGUAN ILBIOGARAN 62,5 mg / 25 mg ENFANTS, comprimé pelliculé ATOVAQUONE/PROGUAN IL ZENTIVA 250 mg/100 mg, comprimé pelliculé Malarone Junior 62,5 mg/25 mg comprimés pelliculés

not available

AA167/01801

UK/H/0558/001

425603

GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

not available

425503

GLAXO GROUP LIMITED

EE

not available

19361

DK

not available

33576

not available

NL22479

not available

NL27585

GLAXOSMITHKLINE PHARMA A/S GLAXOSMITHKLINE PHARMA A/S LABORATOIRE GLAXOSMITHKLINE LABORATOIRE GLAXOSMITHKLINE

not available

NL42884

LABORATOIRE GLAXOSMITHKLINE

FR

not available

NL42822

LABORATOIRE GLAXOSMITHKLINE

FR

not available

NL42821

LABORATOIRE GLAXOSMITHKLINE

FR

not available

NL42885

LABORATOIRE GLAXOSMITHKLINE

FR

UK/H/170/002

BE 248473

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

List of nationally authorised medicinal products EMA/418958/2018

EE

DK FR FR

Page 2/7

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

MT

number Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid Malarone? Junior Filmtabletten|62,5 mg/25 mg Filmtabletten Malarone Παιδιατρικό Δισκίο MALARONE Bambini 62,5 mg/25 mg compresse rivestite con film Malarone Junior 62,5 mg/25 mg comprimés pelliculés Malarone Junior 62,5/25 mg filmomhulde tabletten Malarone Junior 62,5 mg/25 mg filmdrasjerte tabletter Malarone Pediátrico 62,5 mg/25 mg comprimidos recubiertos con película Malarone Junior 62,5/25 mg filmdragerade tabletter Malarone paediatric 62.5mg/25 mg filmcoated tablets Malarone 250 mg/100 mg filmdragerade tabletter

not available

AA167/01801

UK/H/0558/001

425603

UK/H/0170/002

40274.01.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

UK/H/170/002

2487502

GLAXOSMITHKLINE AEBE

GR

UK/H/170/002

033299037

GLAXOSMITHKLINE S.P.A.

IT

UK/H/170/002

260/09 04 0395

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

UK/H/170/002

RVG 28319

GLAXOSMITHKLINE B.V.

NL

UK/H/0170/002

02-1376

GLAXOSMITHKLINE AS

NO

UK/H/170/002

65.257

GLAXOSMITHKLINE S.A.

ES

UK/H/0170/002

18805

GLAXOSMITHKLINE AB

SE

UK/H/0170/002

PL 10949/0363

UK

UK/H/170/001

21375

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK GLAXOSMITHKLINE OY

List of nationally authorised medicinal products EMA/418958/2018

EE

FI

Page 3/7

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

MT

number Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid MALARONE 250 mg/100 mg filmomhulde tabletten Malarone 250 mg/100 mg Filmtabletten Malarone Junior 62,5 mg/25 mg filmomhulde tabletten Malarone Junior 62,5 mg/25 mg Filmtabletten Malarone Junior 62,5 mg/25 mg Filmtabletten Malarone 250 mg/100 mg Filmtabletten MALARONE 250 mg/100 mg filmsko obložene tablete Malarone 250 mg/100 mg Filmtabletten MALARONE 250 mg/100 mg comprimés pelliculés Malarone, potahované tablety 250 mg/100 mg Malarone 250 mg/100 mg tabletti, kalvopäällysteinen Malarone® Filmtabletten 250 mg/100 mg Filmtabletten

not available

AA167/01801

UK/H/0558/001

425603

UK/H/0170/001

BE 186821

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

UK/H/170/001

BE 186821

BE

UK/H/170/002

BE248473

GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA

UK/H/0170/002

BE 248473

BE

UK/H/170/002

260/09 04 0395

UK/H/170/001

0260/09/04/0394

UK/H/170/001

H/06/00962/001

GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE D.O.O.

UK/H/170/001

1-21997

AT

UK/H/170/001

BE 186821

UK/H/0170/001

25/547/05-C

GLAXOSMITHKLINE PHARMA GMBH. GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXO WELLCOME UK LTD

UK/H/170/001

21375

GLAXOSMITHKLINE OY

FI

UK/H/170/001

40274.00.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

List of nationally authorised medicinal products EMA/418958/2018

EE

BE

LU LU SI

BE CZ

Page 4/7

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised MT

number Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid Malarone επικαλυμμένα με λεπτό υμένιο δισκία 250 mg/100 mg Malarone 250 mg/100 mg filmtabletta Malarone 250 mg/100 mg filmuhúðaðar töflur Malarone 250 mg/100 mg film-coated tablets MALARONE 250 mg/100 mg compresse rivestite con film Malarone 250 mg/100 mg apvalkotās tabletes Malarone 250 mg/100 mg plėvele dengtos tabletės MALARONE 250 mg/100 mg comprimés pelliculés Malarone 250/100 mg filmomhulde tabletten Malarone 250 mg/100 mg filmdrasjerte tabletter Malarone, 250 mg + 100 mg, tabletki powlekane Malarone 250 mg/100 mg comprimidos revestidos por película

not available

AA167/01801

UK/H/0558/001

425603

GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

UK/H/170/001

2487501

GLAXOSMITHKLINE AEBE

GR

UK/H/170/001

OGYI-T-20107/01

GLAXOSMITHKLINE KFT.

HU

UK/H/0170/001

IS/1/05/054/01

IS

UK/H/0170/001

PA 1077/111/1

UK/H/170/001

033299013

GLAXOSMITHKLINE PHARMA A/S GLAXOSMITHKLINE (IRELAND) LIMITED GLAXOSMITHKLINE S.P.A.

UK/H/170/001

06-0013

LV

UK/H/170/001

LT/1/06/0441/001

GLAXOSMITHKLINE LATVIA SIA GLAXOSMITHKLINE LIETUVA UAB

UK/H/170/001

2009 04 0394

LU

UK/H/170/001

RVG 25386

GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE B.V.

UK/H/170/001

00-1938

GLAXOSMITHKLINE AS

NO

UK/H/0170/001

12142

PL

UK/H/0170/001

5692587

GLAXOSMITHKLINE EXPORT LTD GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LDA

List of nationally authorised medicinal products EMA/418958/2018

EE

IE IT

LT

NL

PT

Page 5/7

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised MT

number Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid Malarone 250 mg/100 mg filmom obalené tablety Malarone 250 mg/100 mg comprimidos recubiertos con película Malarone 250 mg/100 mg filmdragerade tabletter Malarone 250 mg/100 mg film-coated tablets

not available

AA167/01801

UK/H/0558/001

425603

GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

UK/H/0170/001

25/0127/06-S

GLAXO GROUP LIMITED

SK

UK/H/170/001

63452

GLAXOSMITHKLINE S.A.

ES

UK/H/0170/001

13488

GLAXOSMITHKLINE AB

SE

UK/H/0170/001

PL 10949/0258

UK

Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid Malarone, 250 mg/100 mg õhukese polümeerikattega tabletid Malarone, filmovertrukne tabletter Malarone, filmovertrukne tabletter MALARONE 250 mg/100 mg, comprime pellicule

not available

AA167/01801

UK/H/0558/001

425603

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

not available

425503

GLAXO GROUP LIMITED

EE

not available

19361

DK

not available

33576

not available

NL22479

GLAXOSMITHKLINE PHARMA A/S GLAXOSMITHKLINE PHARMA A/S LABORATOIRE GLAXOSMITHKLINE

List of nationally authorised medicinal products EMA/418958/2018

EE

MT EE

DK FR

Page 6/7

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXO WELLCOME UK LIMITED GLAXO GROUP LIMITED

MT

LABORATOIRE GLAXOSMITHKLINE

FR

number Malarone 250 mg/100 mg film-coated tablets Malarone Paediatric, 62,5 mg/25 mg õhukese polümeerikattega tabletid MALARONE 62,5 mg/25 mg ENFANTS, comprimé pelliculé

not available

AA167/01801

UK/H/0558/001

425603

not available

NL27585

List of nationally authorised medicinal products EMA/418958/2018

EE

Page 7/7

PSUSA/00000266/201710 - European Medicines Agency - europa.eu

Jun 14, 2018 - Malarone Paediatric, 62,5 mg/25 mg õhukese ... MALARONE 62,5 mg/25 .... PL. Malarone 250 mg/100 mg comprimidos revestidos por película.

129KB Sizes 14 Downloads 137 Views

Recommend Documents

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

dexlansoprazole, lansoprazole - European Medicines Agency
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 13 September 2017. EMA/727763/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): dexlansop

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Applicants can request a re-examination. The first four rows present the outcome of the evaluation before a re-examination (or a.

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.